
Results
4
High Growth Stocks
4 companies
Zevra Therapeutics
Market Cap: US$687.1m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$12.13
7D
6.0%
1Y
30.7%
Arcutis Biotherapeutics
Market Cap: US$3.3b
A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
ARQT
US$26.46
7D
0.7%
1Y
67.6%
Kiniksa Pharmaceuticals International
Market Cap: US$6.2b
A biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally.
KNSA
US$80.80
7D
3.4%
1Y
143.3%
Sotera Health
Market Cap: US$5.3b
Provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.
SHC
US$19.00
7D
0.6%
1Y
16.6%